
Marianne P. Allen
Examiner (ID: 17617, Phone: (571)272-0712 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1818, 1812, 1645, 1805, 1631, 1647 |
| Total Applications | 2168 |
| Issued Applications | 1046 |
| Pending Applications | 251 |
| Abandoned Applications | 885 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6593953
[patent_doc_number] => 20100048484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'METHODS FOR TREATING DIABETIC WOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/547256
[patent_app_country] => US
[patent_app_date] => 2009-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 27121
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048484.pdf
[firstpage_image] =>[orig_patent_app_number] => 12547256
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/547256 | Methods for treating diabetic wounds | Aug 24, 2009 | Issued |
Array
(
[id] => 5973260
[patent_doc_number] => 20110152358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'Compositions and Methods for Diagnosis and Treatment of Pancreatic Ductal Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/059088
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9068
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152358.pdf
[firstpage_image] =>[orig_patent_app_number] => 13059088
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059088 | Compositions and Methods for Diagnosis and Treatment of Pancreatic Ductal Cancer | Aug 6, 2009 | Abandoned |
Array
(
[id] => 9440648
[patent_doc_number] => 08709758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-29
[patent_title] => 'Methods and compositions for inhibition of neutrophil exocytosis'
[patent_app_type] => utility
[patent_app_number] => 13/056521
[patent_app_country] => US
[patent_app_date] => 2009-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 14409
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13056521
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/056521 | Methods and compositions for inhibition of neutrophil exocytosis | Jul 27, 2009 | Issued |
Array
(
[id] => 6636285
[patent_doc_number] => 20100035812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Modified Bovine G-CSF Polypeptides And Their Uses'
[patent_app_type] => utility
[patent_app_number] => 12/507237
[patent_app_country] => US
[patent_app_date] => 2009-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 109055
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035812.pdf
[firstpage_image] =>[orig_patent_app_number] => 12507237
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/507237 | Modified bovine G-CSF polypeptides and their uses | Jul 21, 2009 | Issued |
Array
(
[id] => 8257635
[patent_doc_number] => 08207118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-26
[patent_title] => 'Skin wound healing compositions and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/505361
[patent_app_country] => US
[patent_app_date] => 2009-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 12
[patent_no_of_words] => 2722
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12505361
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/505361 | Skin wound healing compositions and methods of use thereof | Jul 16, 2009 | Issued |
Array
(
[id] => 6492603
[patent_doc_number] => 20100093623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING NOD-LIKE RECEPTOR ACTIVITY AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/504649
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 69214
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093623.pdf
[firstpage_image] =>[orig_patent_app_number] => 12504649
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/504649 | COMPOSITIONS AND METHODS FOR MODULATING NOD-LIKE RECEPTOR ACTIVITY AND USES THEREOF | Jul 15, 2009 | Abandoned |
Array
(
[id] => 7696713
[patent_doc_number] => 20110229877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'ENZYME-PORE CONSTRUCTS'
[patent_app_type] => utility
[patent_app_number] => 13/002709
[patent_app_country] => US
[patent_app_date] => 2009-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 30410
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229877.pdf
[firstpage_image] =>[orig_patent_app_number] => 13002709
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/002709 | ENZYME-PORE CONSTRUCTS | Jul 5, 2009 | Abandoned |
Array
(
[id] => 6589387
[patent_doc_number] => 20100130417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'TRANSFORMING GROWTH FACTOR ALPHA HII'
[patent_app_type] => utility
[patent_app_number] => 12/495569
[patent_app_country] => US
[patent_app_date] => 2009-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13651
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130417.pdf
[firstpage_image] =>[orig_patent_app_number] => 12495569
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/495569 | TRANSFORMING GROWTH FACTOR ALPHA HII | Jun 29, 2009 | Abandoned |
Array
(
[id] => 5315964
[patent_doc_number] => 20090280562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'MATERIALS AND METHODS FOR PREPARING DIMERIC GROWTH FACTORS'
[patent_app_type] => utility
[patent_app_number] => 12/494050
[patent_app_country] => US
[patent_app_date] => 2009-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12253
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280562.pdf
[firstpage_image] =>[orig_patent_app_number] => 12494050
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/494050 | MATERIALS AND METHODS FOR PREPARING DIMERIC GROWTH FACTORS | Jun 28, 2009 | Abandoned |
Array
(
[id] => 6477639
[patent_doc_number] => 20100041605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Use of VEGF-C or VEGF-D in Reconstructive Surgery'
[patent_app_type] => utility
[patent_app_number] => 12/490037
[patent_app_country] => US
[patent_app_date] => 2009-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 28449
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20100041605.pdf
[firstpage_image] =>[orig_patent_app_number] => 12490037
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/490037 | Use of VEGF-C or VEGF-D in Reconstructive Surgery | Jun 22, 2009 | Abandoned |
Array
(
[id] => 4493320
[patent_doc_number] => 07956033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-07
[patent_title] => 'Modified peptide of human acidic fibroblast growth factor'
[patent_app_type] => utility
[patent_app_number] => 12/482041
[patent_app_country] => US
[patent_app_date] => 2009-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3168
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/956/07956033.pdf
[firstpage_image] =>[orig_patent_app_number] => 12482041
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/482041 | Modified peptide of human acidic fibroblast growth factor | Jun 9, 2009 | Issued |
Array
(
[id] => 9964787
[patent_doc_number] => 09012399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-21
[patent_title] => 'Controlled release of growth factors and signaling molecules for promoting angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 12/992617
[patent_app_country] => US
[patent_app_date] => 2009-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 10
[patent_no_of_words] => 16128
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12992617
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992617 | Controlled release of growth factors and signaling molecules for promoting angiogenesis | May 31, 2009 | Issued |
Array
(
[id] => 6560266
[patent_doc_number] => 20100233803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'Fusion Polypeptides Capable of Activating Receptors'
[patent_app_type] => utility
[patent_app_number] => 12/466606
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15219
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233803.pdf
[firstpage_image] =>[orig_patent_app_number] => 12466606
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/466606 | Fusion polypeptides capable of activating receptors | May 14, 2009 | Issued |
Array
(
[id] => 6014786
[patent_doc_number] => 20110223147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'LYSOSOMAL TARGETING PEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/991104
[patent_app_country] => US
[patent_app_date] => 2009-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17641
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20110223147.pdf
[firstpage_image] =>[orig_patent_app_number] => 12991104
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/991104 | LYSOSOMAL TARGETING PEPTIDES AND USES THEREOF | May 6, 2009 | Abandoned |
Array
(
[id] => 6142131
[patent_doc_number] => 20110129456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Sequential Administration of Chemotherapeutic Agents for Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/991228
[patent_app_country] => US
[patent_app_date] => 2009-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12237
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129456.pdf
[firstpage_image] =>[orig_patent_app_number] => 12991228
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/991228 | Sequential Administration of Chemotherapeutic Agents for Treatment of Cancer | May 3, 2009 | Abandoned |
Array
(
[id] => 8858576
[patent_doc_number] => 08461112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'HGF preparation'
[patent_app_type] => utility
[patent_app_number] => 12/432651
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4293
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12432651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/432651 | HGF preparation | Apr 28, 2009 | Issued |
Array
(
[id] => 8066239
[patent_doc_number] => 20110243899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein'
[patent_app_type] => utility
[patent_app_number] => 12/988533
[patent_app_country] => US
[patent_app_date] => 2009-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 21616
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20110243899.pdf
[firstpage_image] =>[orig_patent_app_number] => 12988533
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/988533 | Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein | Apr 22, 2009 | Abandoned |
Array
(
[id] => 6234868
[patent_doc_number] => 20100266572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'TREATMENT AND PREVENTION OF ISCHEMIC INJURY USING ACTIVATED PROTEIN C'
[patent_app_type] => utility
[patent_app_number] => 12/423899
[patent_app_country] => US
[patent_app_date] => 2009-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15062
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20100266572.pdf
[firstpage_image] =>[orig_patent_app_number] => 12423899
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/423899 | TREATMENT AND PREVENTION OF ISCHEMIC INJURY USING ACTIVATED PROTEIN C | Apr 14, 2009 | Abandoned |
Array
(
[id] => 4484346
[patent_doc_number] => 07902149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-08
[patent_title] => 'Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins'
[patent_app_type] => utility
[patent_app_number] => 12/422048
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 55411
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/902/07902149.pdf
[firstpage_image] =>[orig_patent_app_number] => 12422048
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422048 | Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins | Apr 9, 2009 | Issued |
Array
(
[id] => 6110218
[patent_doc_number] => 20110189169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'COMBINATION OF HGF INHIBITOR AND PTEN AGONIST TO TREAT CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/935581
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13291
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189169.pdf
[firstpage_image] =>[orig_patent_app_number] => 12935581
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/935581 | COMBINATION OF HGF INHIBITOR AND PTEN AGONIST TO TREAT CANCER | Apr 8, 2009 | Abandoned |